Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to ...

Researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau after demonstrating that this vaccine generated a robust immune response in ...

An experimental vaccine that blocks Alzheimer's-related tau protein buildup has generated a robust immune response in both ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

Lowering levels of circulating transthyretin with vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) decreased their risk for mortality and cardiovascular events ...

CHICAGO — RNA therapeutics improved survival, 6-minute walk distance and quality of life for patients with transthyretin amyloid cardiomyopathy, according to study results presented at the ...

Phase 3 – REVEAL study with 124 I-evuzamitide in patients with suspected cardiac amyloidosis is ongoing by Brigham and Women’s Hospital, Boston, MA. AT-05 (99mTc-p5+14), a radiotracer ...

How do you decide whether to continue or discontinue treatment with an amyloid-targeting therapy?